Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Atekka is a new generation agricultural insurance company.
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
Provivi develops biopesticides for agriculture, commercial, household, and public health pest management.
AN2 Therapeutics develops small-molecule medicines from boron chemistry for infectious diseases, hematologic disorders, and oncology.
Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.
Serán Bioscience is a contract development and manufacturing organization.
Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Expedition Therapeutics develops treatments for COPD and other inflammatory respiratory diseases.
A private biopharmaceutical company .
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Telum Therapeutics is a biotechnology company that develops antimicrobial therapies to combat multidrug-resistant bacterial infections.
Ocelot Bio brings new treatment options to patients with severe liver disease.
Inspirna is a biotechnology company developing drugs for the treatment of cancer.
Swift Health Systems is a stealth stage start-up medical device company, developing INBRACE.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.
Vivo Capital has invested in 167 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Vivo Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Life Science. The firm invests across 23 different industry categories.
Among tracked funding rounds, Celcuity received $500.0M in a Post-IPO Debt round. Vivo Capital's total known invested capital is $18.9B.
Vivo Capital's average investment size is $138.0M across its portfolio of 167 companies.
Recent Vivo Capital portfolio additions include Atekka, IO Biotech, Provivi, AN2 Therapeutics, Semnur Pharmaceuticals. These companies were founded in 2020 or later.